Skip to search formSkip to main contentSkip to account menu

imirestat

Known as: 2,7-Difluorospiro(fluorene-9,4'-imidazolidine)-2',5'-dione, spiro(2,7-difluoro-9H-fluoren-9,4'-imidazolidine)-2',5'-dione 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The pharmacokinetics of imirestat were studied in healthy volunteers following single and multiple oral doses. After single doses… 
1998
1998
This study examined links between impaired nitric oxide production in the sciatic endoneurium, nerve blood flow, and polyol… 
Review
1994
Review
1994
Summary— Research into the biological basis of lens transparency has demonstrated the implication of lens sugar stress in the… 
1992
1992
1. Urine from a dog dosed orally at 20 mg/kg with 14C-imirestat, a spirohydantoin aldose reductase inhibitor, contained 17.7 and… 
1990
1990
The pharmacokinetics of imirestat following topical ocular administration were evaluated in a series of studies in rabbits and… 
1989
1989
Internal surface reversed-phase (ISRP) columns have been designed to facilitate the HPLC analysis of drugs in blood serum or…